June 28, 2010
OraQuick HCV Rapid Antibody Test approvedThe FDA has approved the OraQuick HCV Rapid Antibody Test (from OraSure) to test individuals who are at risk for infection with hepatitis C virus (HCV) and people with signs or symptoms of hepatitis. OraQuick HCV is a test strip and does not require an instrument for diagnosis. Results can be obtained within 20 minutes. OraQuick HCV may be used in patients ≥15 years of age.
For more information www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm217318.htm.